Drug Repurposing in Cancer — Why Fenbendazole and Ivermectin Are Being Studied

A billion dollars, ten years, and the case for repurposing old drugs Why are two antiparasitic drugs suddenly in every cancer conversation? It comes down to drug repurposing — studying an old, proven medicine for a new use. A new cancer drug costs over a billion dollars and a decade to develop; a drug with decades of safety data can skip much of that. In this video, you'll learn why fenbendazole and ivermectin became research candidates — and why the gaps in human proof matter just as much as the promising lab data. Comment or Message REPURPOSED for a link to the full research blog. 🎓 POC Learning Center → prevailovercancer.com/learning-center 👥 Cancer Coaching Assessment and Consultation → prevailovercancer.com/coaching 📚 POC Academy → prevailovercancer.com/academy ▶️ Subscribe →    / @prevailovercancer   🎙️ POC Podcast Playlist →    • Prevail Over Cancer Podcast Show   Together — We Prevail Over Cancer!™ Prevail. Assess. Don’t Guess.™ ⚠️ This video is for educational purposes only and is not medical advice. Fenbendazole is an FDA-approved veterinary anthelmintic and is not FDA-approved to treat cancer in humans. Ivermectin is FDA-approved for certain human parasitic infections and is not FDA-approved to treat cancer. Use outside approved indications is off-label and may carry risks, including drug interactions. Always consult your oncology team and a clinician familiar with integrative oncology. Never stop conventional cancer treatment without your oncologist’s guidance. These statements have not been evaluated by the Food and Drug Administration.